Til Schlotter
Co-founder & CEO at UNOMR, CH
More information
Biography
Til Schlotter earned his BSc and MSc in Engineering from ETH Zurich and completed his diploma thesis at the University of British Columbia. He later completed his PhD at ETH Zurich, where he pioneered the development of the interface nanopore technology that powers UNOMR’s innovative approach to proteomics and precision medicine.
As CEO of UNOMR, he leads application development, customer engagement, and fundraising to bring UNOMR’s platform to the market. Under his leadership, the company has secured support from programs such as Innosuisse and Venture Kick advancing its mission to make high-resolution protein modification analysis widely accessible across pharmaceutical R&D, biotech, and food science.